ジクロフェナミド
- 関
- dichlorphenamide
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/11/26 19:52:57」(JST)
[Wiki en表示]
Diclofenamide
|
|
Systematic (IUPAC) name |
4,5-dichlorobenzene-1,3-disulfonamide |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
MedlinePlus |
a601233 |
Pregnancy cat. |
? |
Legal status |
? |
Pharmacokinetic data |
Protein binding |
55% |
Identifiers |
CAS number |
120-97-8 Y |
ATC code |
S01EC02 |
PubChem |
CID 3038 |
DrugBank |
DB01144 |
ChemSpider |
2930 Y |
UNII |
VVJ6673MHY Y |
KEGG |
D00518 Y |
ChEBI |
CHEBI:101085 Y |
ChEMBL |
CHEMBL17 Y |
Chemical data |
Formula |
C6H6Cl2N2O4S2 |
Mol. mass |
305.16 g/mol |
SMILES
- Clc1c(cc(cc1Cl)S(=O)(=O)N)S(=O)(=O)N
|
InChI
-
InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14) Y
Key:GJQPMPFPNINLKP-UHFFFAOYSA-N Y
|
N (what is this?) (verify)
|
Diclofenamide (or dichlorphenamide) is a sulfonamide and a carbonic anhydrase inhibitor of the meta-Disulfamoylbenzene class.
Uses[edit]
Diclofenamide is often used to treat therapy-resistant epilepsy.[1]
References[edit]
- ^ "Diclofenamide in the treatment of therapy-resistant epilepsy.". PubMed. Retrieved 13 May 2013.
- Tawil R, McDermott M, Brown R, Shapiro B, Ptacek L, McManis P, Dalakas M, Spector S, Mendell J, Hahn A, Griggs R (2000). "Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis.". Ann Neurol 47 (1): 46–53. doi:10.1002/1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H. PMID 10632100.
- Okada S, Izumi W, Murai M, Komatsu H, Ishimitsu S (1991). "[Diclofenamide Reference Standard (Control 891) of National Institute of Hygienic Sciences]". Eisei Shikenjo Hokoku 109 (109): 148–50. PMID 1364383.
Ophthalmologicals: antiglaucoma preparations and miotics (S01E)
|
|
Sympathomimetics |
- Apraclonidine
- Brimonidine (+timolol)
- Clonidine
- Dipivefrine
- Epinephrine
|
|
Parasympathomimetics |
muscarinic
|
|
|
muscarinic/nicotinic
|
|
|
Acetylcholinesterase inhibitors
|
- Demecarium
- Ecothiopate
- Stigmine (Fluostigmine
- Neostigmine
- Physostigmine)
- Paraoxon
|
|
|
Carbonic anhydrase inhibitors/
(sulfonamides) |
- Acetazolamide
- Brinzolamide (+timolol)
- Diclofenamide
- Dorzolamide (+timolol)
- Methazolamide
|
|
Beta blocking agents |
- Befunolol
- Betaxolol
- Carteolol
- Levobunolol
- Metipranolol
- Timolol
- Mepindolol
|
|
Prostaglandin analogues (F2α) |
- Bimatoprost (+timolol)
- Latanoprost (+timolol)
- Tafluprost
- Travoprost (+timolol)
- Unoprostone
|
|
Other agents |
|
|
|
anat (g/a/p)/phys/devp/prot
|
|
proc, drug (S1A/1E/1F/1L)
|
|
|
|
English Journal
- Analysis of gene profiles in glioma cells identifies potential genes, miRNAs, and target sites of migratory cells.
- Xue F1, Shen R, Chen X.
- Tumori.Tumori.2015 May 1;0(0):0. doi: 10.5301/tj.5000226. [Epub ahead of print]
- AIMS: To explore the potential molecular mechanisms involved in migratory glioma cells.METHODS: The gene expression profiles of GSE28167, employing human malignant glioma U251MG cells cultured on strictly aligned versus randomly oriented electrospun nanofibers of polycaprolactone, were downloaded fr
- PMID 25953448
- Emerging role of calcium-activated potassium channel in the regulation of cell viability following potassium ions challenge in HEK293 cells and pharmacological modulation.
- Tricarico D1, Mele A, Calzolaro S, Cannone G, Camerino GM, Dinardo MM, Latorre R, Conte Camerino D.
- PloS one.PLoS One.2013 Jul 16;8(7):e69551. doi: 10.1371/journal.pone.0069551. Print 2013.
- Emerging evidences suggest that Ca(2+)activated-K(+)-(BK) channel is involved in the regulation of cell viability. The changes of the cell viability observed under hyperkalemia (15 mEq/L) or hypokalemia (0.55 mEq/L) conditions were investigated in HEK293 cells expressing the hslo subunit (hslo-HEK29
- PMID 23874973
- Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.
- Konstantopoulos N1, Molero JC, McGee SL, Spolding B, Connor T, de Vries M, Wanyonyi S, Fahey R, Morrison S, Swinton C, Jones S, Cooper A, Garcia-Guerra L, Foletta VC, Krippner G, Andrikopoulos S, Walder KR.
- Diabetes.Diabetes.2012 Aug;61(8):2146-54. doi: 10.2337/db11-0578. Epub 2012 May 14.
- We previously used Gene Expression Signature technology to identify methazolamide (MTZ) and related compounds with insulin sensitizing activity in vitro. The effects of these compounds were investigated in diabetic db/db mice, insulin-resistant diet-induced obese (DIO) mice, and rats with streptozot
- PMID 22586591
Related Links
- Structure, properties, spectra, suppliers and links for: Diclofenamide. ... Predicted data is generated using the US Environmental Protection Agency’s EPISuite , for more information see their website. Log Octanol-Water Partition ...
- Find quality suppliers and manufacturers of Diclofenamidefor price inquiry.where to buy Diclofenamide.Also offer free database of Diclofenamide including MSDS sheet(poisoning, toxicity, hazards and safety),chemical properties ...
Related Pictures
★リンクテーブル★
[★]
ジクロフェナミド
- 関
- diclofenamide
[★]
- 英
- dichlorphenamide、diclofenamide